Importantly, high RBP4 levels could be a marker of NAFLD development, and the lower levels of RBP4 may also be an indicator of the progression ot NASH with fibrosis among NAFLD disease stages [297,298]. This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatohepatitis.